Summit Therapeutics (SMMT) Price to Earnings (2017 - 2024)
Powered by 
Analysis
Summit Therapeutics (SMMT) Price to Earnings (2017 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Summit Therapeutics | 13.67 Bn | 12.98 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -200.58 |
| Sep 30, 2024 | -265.36 |
| Jun 30, 2024 | -90.08 |
| Mar 31, 2024 | -63.86 |
| Dec 31, 2023 | -50.58 |
| Sep 30, 2023 | -63.68 |
| Jun 30, 2023 | -110.88 |
| Mar 31, 2023 | -1.23 |
| Dec 31, 2022 | -44.20 |
| Sep 30, 2022 | -10.44 |
| Jun 30, 2022 | -7.73 |
| Mar 31, 2022 | -10.85 |
| Dec 31, 2021 | -9.73 |
| Sep 30, 2021 | -24.96 |
| Jun 30, 2021 | -29.74 |
| Mar 31, 2021 | -27.83 |
| Dec 31, 2020 | -28.66 |
| Sep 30, 2020 | -13.03 |
| Jun 30, 2020 | -13.07 |
| Mar 31, 2020 | -25.18 |